These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4314784)

  • 21. [Combined treatment of multiple sclerosis. A case report].
    Fonseca A; Noda M; González I; Gámez O; Montoya A; Daudinot B
    Rev Neurol; 2001 May 16-31; 32(10):996-8. PubMed ID: 12809119
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of polyamine in the complex treatment of multiple sclerosis].
    Gusev EI; Karneev AN; Ivanokov AN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(8):1126-31. PubMed ID: 4050223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple sclerosis: a chronic-care focus.
    Albion JH
    Nurse Pract; 1983 Apr; 8(4):29-35. PubMed ID: 6304587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiological studies on peripheral nervous function in multiple sclerosis.
    Rinne UK; Tuovinen T
    Ann Med Intern Fenn; 1968; 57(4):173-7. PubMed ID: 4307480
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatments of multiple sclerosis].
    Roullet R
    Rev Prat; 1991 Sep; 41(20):1919-23. PubMed ID: 1656516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current methods of therapy in multiple sclerosis.
    Sibley WA
    Mod Treat; 1970 Sep; 7(5):918-29. PubMed ID: 4326377
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic problems in disseminated encephalomyelitis (multiple sclerosis)].
    Payk TR
    Ther Ggw; 1973 Mar; 112(3):349-50. PubMed ID: 4573496
    [No Abstract]   [Full Text] [Related]  

  • 28. [Recent notions concerning the treatments used in multiple sclerosis (author's transl)].
    Gonsette RE
    J Belge Med Phys Rehabil; 1978; 1(3):213-6. PubMed ID: 231031
    [No Abstract]   [Full Text] [Related]  

  • 29. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam.
    Groves L; Shellenberger MK; Davis CS
    Adv Ther; 1998; 15(4):241-51. PubMed ID: 10186943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Trials of Synacthen in multiple sclerosis].
    Badino R
    Riv Neurol; 1970; 40(3):139-64. PubMed ID: 4321924
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experience with the therapy of multiple sclerosis using ACTH].
    Carella A; Lamberti P
    Acta Neurol (Napoli); 1969; 24(6):836-51. PubMed ID: 4314191
    [No Abstract]   [Full Text] [Related]  

  • 32. [The therapeutic effect of corticosteroids on the symptoms and course of multiple sclerosis].
    Mayer K; Trübestein G; Diefenbach C
    Med Welt; 1970 Mar; 10():392-5. PubMed ID: 4314318
    [No Abstract]   [Full Text] [Related]  

  • 33. [Abuse of Carisoprodol].
    Lindberg N; Lauerma H
    Duodecim; 1996; 112(2):109-11. PubMed ID: 10590614
    [No Abstract]   [Full Text] [Related]  

  • 34. Drugs in dentistry. Muscle relaxants.
    Ciancio SG
    Dent Manage; 1985 Dec; 25(12):56, 59-60. PubMed ID: 3866707
    [No Abstract]   [Full Text] [Related]  

  • 35. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data.
    Owens C; Pugmire B; Salness T; Culbertson V; Force R; Cady P; Steiner J
    Clin Ther; 2007 Oct; 29(10):2222-5. PubMed ID: 18042478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of the patient with multiple sclerosis.
    Walker JE
    Compr Ther; 1982 May; 8(5):20-3. PubMed ID: 6284439
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative evaluation of methods of treating multiple sclerosis].
    Briskman AN
    Vrach Delo; 1966 Sep; 9():147-8. PubMed ID: 4175862
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pathogenetic therapy of multiple sclerosis].
    Veĭn AM; Smirnov IuK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(2):181-5. PubMed ID: 6858476
    [No Abstract]   [Full Text] [Related]  

  • 39. Advances in neurology.
    Matthews WB
    Practitioner; 1972 Oct; 209(252):481-8. PubMed ID: 4342782
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effect of Mydeton on the psychic activity in cases of mental retardation].
    Schwabik J; Péterfai J
    Orv Hetil; 1967 Jan; 108(4):157-60. PubMed ID: 6047454
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.